The topics of the seemingly inadvertently exposed chats ranged from erotica, programming chats, work notes, and…
MAP Context™
MAP Context™ Context Analysis Narrative Analysis Media Context Reports Source Context Reports Transparency ExplanationsMAP Intelligence
MAP Intelligence Sports Intelligence Business Intelligence Technology Intelligence Healthcare Intelligence Entertainment IntelligenceCategory
Business news and market intelligence covering corporate earnings, M&A, private equity, economic policy, and financial markets. MAP Verified sourcing.
“His proposal involves a proprietary equity hedge strategy to manage $700,000 of my assets.”
The topics of the seemingly inadvertently exposed chats ranged from erotica, programming chats, work notes, and…
This small-cap fund is built to win the earnings-report games companies play
Brandon Nelson of Calamos Investments considers the earnings-season beat-and-raise pattern in identifying companies primed for sustainable…
Jeff Bezos Changed His Mind About Long Hours. Science Suggests He Was Right
A large-scale study reveals that one common habit may undermine judgment, increase risk-taking, and hurt productivity…
Gap Is Bringing Back Its Beloved ’90s Fragrances. Millennials Are Losing Their Minds
‘Best news ever!’ one customer wrote on Instagram.
When governments began to treat guano as a strategic resource, Congress responded with the Guano Islands…
Cold Brew Recall: 3,000 Gallons of Coffee Pulled Over Fears of a Rare Toxin That Can Cause Paralysis
A well-known coffee company recently issued a voluntary recall for one of its signature products.
SpaceX’s stock falls to a new low despite a near-flawless Starship flight
SpaceX’s earnings report next week could unleash a further wave of selling, as some insiders will…
‘I feel lucky’: I’m 71 and inherited $20,000. What should I do with this money?
“I have an IRA, a high-yield savings account, four CDs and checking and savings accounts.”
Think GLP-1s Are Too Expensive for Your Health Plan? Cutting Them Might Hurt Your Bottom Line
A new study reveals that dropping coverage for weight-loss drugs like Ozempic could backfire—costing companies up…